Monday–Thursday: 8:30AM–6:00PM PST

Home
Active Studies
Participate in a Study
About Us
- Privacy Policy

Active Clinical Trials and Studies

Excell Research may be seeking participants for an upcoming clinical research study for an area or disease that is relevant to you or someone you know.

Clinical Research Trials

Clinical research trials and those who contribute play a role in the development of new treatments for some of our most common and debilitating diseases and conditions.

Patients who participate in Excell’s clinical research trials have an opportunity to join the vanguard of scientific research and contribute to the progress, knowledge, and future treatment of medical conditions.

We will provide you with comprehensive information and straightforward answers to your questions regarding the risks and benefits of participating.

Financial compensation may be available to those who qualify and complete visits for clinical trials at Excell.

Depression Clinical Research Trials

Major Depressive Disorder Clinical Trials

Summary: The purpose of these studies are to determine safety and efficacy of the investigational medication compared to placebo, used either as monotherapy or adjunctively to an antidepressant, related to patient characteristics.

Eligibility Criteria

Key Inclusion Criteria:

Symptoms of depression for at least 6 weeks prior to entering the study.
Willing to comply with all study assessments and procedures.

Key Exclusion Criteria:

Diagnosed with bi-polar disorder, schizophrenia, psychotic disorders, or dementia.
Clinically significant medical conditions.
History of substance abuse in the past 3 months.

Patient Time Reimbursed?

Yes

Patient Travel Reimbursed?

Yes

Age:

18-75

Sign-Up

Generalized Anxiety Clinical Research Trials

Generalized Anxiety Disorder (GAD) Trials

Summary: The purpose of these studies are to determine safety and efficacy of the investigational medication compared to placebo, used either as monotherapy or adjunctively in adults with Generalized Anxiety Disorder. The investigational product is in the form of a tablet.

Eligibility Criteria:

Key Inclusion Criteria:

Male or female subject over the age of 18
Currently experiencing symptoms of Generalized Anxiety Disorder
Primary focus of treatment is Generalized Anxiety Disorder.

Key Exclusion Criteria:

Diagnosis other than Generalized Anxiety Disorder that was the primary focus of treatment within 12 months before Screening.
Any clinically significant unstable medical condition or any clinically significant chronic disease, that would limit the subject’s ability to complete and/or participate in the study.

Patient Time Reimbursed?

Yes

Patient Travel Reimbursed?

Yes

Age:

18 and above

Sign-Up

Schizophrenia Clinical Research Trials

Schizophrenia Trial

Summary: Study to evaluate the safety and efficacy of iloperidone in preventing relapse in participants with schizophrenia.

Eligibility Criteria

Key Inclusion Criteria:

Diagnosis of Schizophrenia
Willing to comply with all study assessments and procedures.

Key Exclusion Criteria:

Diagnosed with bi-polar disorder or other non-schizophrenic psychotic disorders.
Current substance/alcohol abuse.
Clinically significant medical conditions.

Patient Time Reimbursed?

Yes

Patient Travel Reimbursed?

Yes

Age:

18-65

Sign-Up

Social Anxiety Disorder Clinical Research Trials

Social Anxiety Clinical Research Trials

Summary Trial A: The study’s purpose is to evaluate the efficacy and safety of Fasedienol as monotherapy compared to placebo in subjects with Social Anxiety Disorder. The investigational medication is in the form of a nasal spray.

Summary Trial B: The study’s purpose is to evaluate the efficacy and safety of BNC210 as monotherapy compared to placebo in subjects with Social Anxiety Disorder. The investigational medication is in the form of a tablet.

Eligibility Criteria:

Key Inclusion Criteria:

Currently experiencing symptoms of social anxiety disorder.
Willing to stop exclusionary psychiatric medications prior to study entry.

Key Exclusion Criteria:

Lifetime history of bi-polar disorder, schizophrenia, borderline personality disorder or autism spectrum disorders.
Unwilling to discontinue exclusionary medications or comply with study procedures.
Any clinically significant unstable medical condition or any clinically significant chronic disease.

Patient Time Reimbursed?

Yes

Patient Travel Reimbursed?

Yes

Age:

18 to 65

Sign-Up

Adolescent Migraine Clinical Research Trials

Adolescent Migraine Trials

Summary: Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraines are extremely common and disabling in children. The purpose of these studies are to evaluate the efficacy and safety of the investigational products Ubrogepant and Atogepant.

Ubrogepant is a drug approved for the acute treatment of migraine in adults and Atogepant is a drug approved for the for the preventive treatment of episodic migraine in adults.

Eligibility Criteria

Key Inclusion Criteria:

History of migraines for at least 6 months.
History of more than 1 migraine per month.

Key Exclusion Criteria:

Any clinically significant hematologic, endocrine, pulmonary, renal, hepatic, gastrointestinal, cardiovascular, or neurologic disease.
Other confounding pain syndromes, confounding psychiatric conditions, or other significant neurological disorders other than migraine.

Patient Time Reimbursed?

Yes

Patient Travel Reimbursed?

Yes

Age:

12-17

Sign-Up

Excell Research Clinical Research StudiesQuick Sign Up Form

Please enable JavaScript in your browser to complete this form.

Name *

First

Last

Please provide your legal name.

Phone *

Please provide the best number to reach you, including the area code.

Email *

Please provide the best email to reach you.

Birth Date *

Please provide your date of birth.

Zip Code *

Please provide your zip code for location verification

I identify as: *

Do you currently have, or have you ever had, any of the following? *

Alzheimer’s Disease
Anxiety Disorders
Bi-Polar Disorder
Depression
Obsessive Compulsive Disorder (OCD)
Post Traumatic Stress Disorder (PTSD)
Schizophrenia
Other Medical Conditions: Please Specify

Are you willing to take an investigational medication as a part of the trial? *

Any questions or comments?

Best Time and Date for us to reach you *

Date

Time

Please let us know your preferred date and time for the call.
Expect a call from Excell Research Monday through Thursday between 8:30am and 6:00pm PT at 760-758-2222

How did you hear about us?

Excell Research Clinical Research StudiesWhy Participate?

For those interested in participating in clinical research trials, Excell has a variety of studies that are testing new or investigational medications at no cost to clinical research study participants! Learn more about how new treatments may help with your symptoms.

Learn More About Clinical Research Trials

Participants

What are Clinical Research Trials?

Clinical research trials offer patients new opportunities for diverse treatments and personalized care from healthcare professionals. These trials often provide financially feasible treatment options, contributing to medical progress and advancing patient care.

New Treatments For Longer and Better-Quality Lives

The primary aim of clinical research trials is to establish the effectiveness and safety of new treatments, potentially offering cures or improved management for chronic conditions. Participating in these trials allows access to cutting-edge treatments while contributing to longer, higher-quality lives for others.

Patient Safety

To ensure the safety of patients during clinical research trials, Excell follows guidelines set by organizations such as the U.S. Food & Drug Administration and the Global International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use Good Clinical Practices (ICH GCP).

According to requirements of the Medical Board of California, medical providers at Excell Research are providing information about the Open Payments Database. The Open Payments database is a federal tool used to search payments made by drug and device companies to physicians and teaching hospitals. It can be found at https://openpaymentsdata.cms.gov. This database was created so that patients can be informed of any possible influence pharmaceutical companies may have on their physician. As a dedicated research facility, the entirety of Excell Research’s income is from pharmaceutical companies; however, medical providers are paid for their work by Excell Research and not directly by any pharmaceutical company.

Learn more about the company on the About Us page.

Get updates on Clinical Trials and Studies at Excell ResearchSign up for monthly updates for Clinical Trials and Studies at Excell Research

In partnership with Researchify Health, refer someone you known or sign up to receive digital communications about current and upcoming studies at Excell.

Monthly Study Updates

https://excellresearch.com/wp-content/uploads/2023/08/qtq80-lHlUrD.jpeg

First Name*:

Last Name*:

Email*:

Phone Number*:

Your age:

I identify as:
MaleFemaleNon-BinaryOther

Do you currently have, or have you ever had, any of the following?
ADHDAlzheimer’s DiseaseAnxiety DisorderBipolar DisorderBorderline Personality DisorderDepressionMigrainesMild Cognitive Impairment/MemoryObsessive Compulsive DisorderPost-Partum DepressionPTSDSchizophreniaOther Psychiatric DisorderOtherUnsureNone of these apply

How did you hear about us?*

*Required

Active Clinical Trials and Studies

Excell Research may be seeking participants for an upcoming clinical research study for an area or disease that is relevant to you or someone you know.

Clinical Research Trials

Clinical research trials and those who contribute play a role in the development of new treatments for some of our most common and debilitating diseases and conditions.

We will provide you with comprehensive information and straightforward answers to your questions regarding the risks and benefits of participating.

Financial compensation may be available to those who qualify and complete visits for clinical trials at Excell.

Depression Clinical Research Trials

Major Depressive Disorder Clinical Trials

Eligibility Criteria

Key Inclusion Criteria:

Symptoms of depression for at least 6 weeks prior to entering the study.
Willing to comply with all study assessments and procedures.

Key Exclusion Criteria:

Diagnosed with bi-polar disorder, schizophrenia, psychotic disorders, or dementia.
Clinically significant medical conditions.
History of substance abuse in the past 3 months.

Patient Time Reimbursed?

Yes

Patient Travel Reimbursed?

Yes

Age:

18-75

Sign-Up

Generalized Anxiety Clinical Research Trials

Generalized Anxiety Disorder (GAD) Trials

Eligibility Criteria:

Key Inclusion Criteria:

Male or female subject over the age of 18
Currently experiencing symptoms of Generalized Anxiety Disorder
Primary focus of treatment is Generalized Anxiety Disorder.

Key Exclusion Criteria:

Diagnosis other than Generalized Anxiety Disorder that was the primary focus of treatment within 12 months before Screening.
Any clinically significant unstable medical condition or any clinically significant chronic disease, that would limit the subject’s ability to complete and/or participate in the study.

Patient Time Reimbursed?

Yes

Patient Travel Reimbursed?

Yes

Age:

18 and above

Sign-Up

Schizophrenia Clinical Research Trials

Schizophrenia Trial

Summary: Study to evaluate the safety and efficacy of iloperidone in preventing relapse in participants with schizophrenia.

Eligibility Criteria

Key Inclusion Criteria:

Diagnosis of Schizophrenia
Willing to comply with all study assessments and procedures.

Key Exclusion Criteria:

Diagnosed with bi-polar disorder or other non-schizophrenic psychotic disorders.
Current substance/alcohol abuse.
Clinically significant medical conditions.

Patient Time Reimbursed?

Yes

Patient Travel Reimbursed?

Yes

Age:

18-65

Sign-Up

Social Anxiety Disorder Clinical Research Trials

Social Anxiety Clinical Research Trials

Eligibility Criteria:

Key Inclusion Criteria:

Currently experiencing symptoms of social anxiety disorder.
Willing to stop exclusionary psychiatric medications prior to study entry.

Key Exclusion Criteria:

Lifetime history of bi-polar disorder, schizophrenia, borderline personality disorder or autism spectrum disorders.
Unwilling to discontinue exclusionary medications or comply with study procedures.
Any clinically significant unstable medical condition or any clinically significant chronic disease.

Patient Time Reimbursed?

Yes

Patient Travel Reimbursed?

Yes

Age:

18 to 65

Sign-Up

Adolescent Migraine Clinical Research Trials

Adolescent Migraine Trials

Ubrogepant is a drug approved for the acute treatment of migraine in adults and Atogepant is a drug approved for the for the preventive treatment of episodic migraine in adults.

Eligibility Criteria

Key Inclusion Criteria:

History of migraines for at least 6 months.
History of more than 1 migraine per month.

Key Exclusion Criteria:

Any clinically significant hematologic, endocrine, pulmonary, renal, hepatic, gastrointestinal, cardiovascular, or neurologic disease.
Other confounding pain syndromes, confounding psychiatric conditions, or other significant neurological disorders other than migraine.

Patient Time Reimbursed?

Yes

Patient Travel Reimbursed?

Yes

Age:

12-17

Sign-Up

Excell Research Clinical Research StudiesQuick Sign Up Form

Please enable JavaScript in your browser to complete this form.

Name *

First

Last

Please provide your legal name.

Phone *

Please provide the best number to reach you, including the area code.

Email *

Please provide the best email to reach you.

Birth Date *

Please provide your date of birth.

Zip Code *

Please provide your zip code for location verification

I identify as: *

Do you currently have, or have you ever had, any of the following? *

Alzheimer’s Disease
Anxiety Disorders
Bi-Polar Disorder
Depression
Obsessive Compulsive Disorder (OCD)
Post Traumatic Stress Disorder (PTSD)
Schizophrenia
Other Medical Conditions: Please Specify

Are you willing to take an investigational medication as a part of the trial? *

Any questions or comments?

Best Time and Date for us to reach you *

Date

Time

Please let us know your preferred date and time for the call.
Expect a call from Excell Research Monday through Thursday between 8:30am and 6:00pm PT at 760-758-2222

How did you hear about us?

Excell Research Clinical Research StudiesWhy Participate?

Learn More About Clinical Research Trials

Participants

What are Clinical Research Trials?

New Treatments For Longer and Better-Quality Lives

Patient Safety

Learn more about the company on the About Us page.

Get updates on Clinical Trials and Studies at Excell ResearchSign up for monthly updates for Clinical Trials and Studies at Excell Research

In partnership with Researchify Health, refer someone you known or sign up to receive digital communications about current and upcoming studies at Excell.

Monthly Study Updates

First Name*:

Last Name*:

Email*:

Phone Number*:

Your age:

I identify as:
MaleFemaleNon-BinaryOther

How did you hear about us?*

*Required

Home
Excell Active Clinical Trials
Participate in Clinical Trial Studies
The Excell Team
Contact
Privacy Policy